SCHEMBL741731

SCHEMBL741731

CC(C)(NC(=O)c1cc2c(NC(=O)c3ccc(CN4CCC4)cc3)n[nH]c2s1)c1cccc(F)c1

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ABL1 P00519 2/20 0.61
BCR P11274 2/20 0.61
AURKA O14965 2/20 0.45
CYP2C9 P11712 1/20 0.43
CCR2 P41597 3/20 0.40
ALK Q9UM73 2/20 0.39
KDR P35968 1/20 0.39
ACKR3 P25106 2/20 0.38
ALDH1A1 P00352 2/20 0.38
RAB9A P51151 2/20 0.38
NPC1 O15118 1/20 0.38
TP53 P04637 1/20 0.38
SMN1; SMN2 Q16637 1/20 0.38
NTRK1 P04629 2/20 0.38
KIT P10721 1/20 0.38
FLT3 P36888 1/20 0.38
HIF1A Q16665 2/20 0.38
EPAS1 Q99814 2/20 0.38
HRH3 Q9Y5N1 1/20 0.38
KDM4E B2RXH2 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL740581 0.98 ABL1 (0.63) ABL1BCRAURKACYP2C9CCR2
SCHEMBL742939 0.98 ABL1 (0.64) ABL1BCRAURKACYP2C9CCR2
SCHEMBL742340 0.93 ABL1 (0.55) ABL1BCRAURKAALKKDR
SCHEMBL742951 0.92 ABL1 (0.62) ABL1BCRAURKACYP2C9KDR
SCHEMBL740623 0.91 ABL1 (0.72) ABL1BCRAURKACYP2C9KDR
SCHEMBL742130 0.91 ABL1 (0.64) ABL1BCRAURKACYP2C9KDR
SCHEMBL742456 0.90 ABL1 (0.65) ABL1BCRAURKACYP2C9KDR
SCHEMBL742638 0.90 ABL1 (0.74) ABL1BCRAURKACYP2C9KDR
SCHEMBL740798 0.90 ABL1 (0.59) ABL1BCRAURKACYP2C9CCR2
SCHEMBL741183 0.89 ABL1 (0.76) ABL1BCRAURKACYP2C9KDR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8138217-B2 Aurora kinase inhibitors; proliferative disorders; anticancer agents; antitumor agents; N-(1-methyl-1-phenylethyl)-3-((4-morpholin-4-ylbenzoyl)amino)-1H-thieno(2,3-c)pyrazole-5-carboxamide NERVIANO MEDICAL SCIENCES S.R.L. (IT) 2012-03-20 US claimed
US-8138217-B2 Aurora kinase inhibitors; proliferative disorders; anticancer agents; antitumor agents; N-(1-methyl-1-phenylethyl)-3-((4-morpholin-4-ylbenzoyl)amino)-1H-thieno(2,3-c)pyrazole-5-carboxamide NERVIANO MEDICAL SCIENCES S.R.L. (IT) 2012-03-20 US disclosed
EP-2007380-A2 USE OF A KINASE INHIBITOR FOR THE TREATMENT OF PARTICULAR RESISTANT TUMORS Nerviano Medical Sciences S.r.l. (IT) 2008-12-31 EP disclosed
WO-2007113198-A2 USE OF A KINASE INHIBITOR FOR THE TREATMENT OF PARTICULAR RESISTANT TUMORS NERVIANO MEDICAL SCIENCES S.R.L. (IT) 2007-10-11 WO disclosed